Organ‐protective effects and the underlying mechanism of dexmedetomidine

N Bao, B Tang - Mediators of inflammation, 2020 - Wiley Online Library
Dexmedetomidine (DEX) is a highly selective α2 adrenergic receptor (α2AR) agonist
currently used in clinical settings. Because DEX has dose‐dependent advantages of …

Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update

J Gracia-Sancho, A Casillas-Ramirez… - Clinical Science, 2015 - portlandpress.com
Ischaemia/reperfusion injury is an important cause of liver damage during surgical
procedures such as hepatic resection and liver transplantation, and represents the main …

Dexmedetomidine alleviates lipopolysaccharide‐induced acute kidney injury by inhibiting p75NTR‐mediated oxidative stress and apoptosis

Z Wang, J Wu, Z Hu, C Luo, P Wang… - … medicine and cellular …, 2020 - Wiley Online Library
Oxidative stress and apoptosis play a key role in the pathogenesis of sepsis‐associated
acute kidney injury (AKI). Dexmedetomidine (DEX) may present renal protective effects in …

Dexmedetomidine ameliorates lipopolysaccharide‐induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK‐3β/Nrf2 signaling …

X Feng, W Guan, Y Zhao, C Wang… - Journal of cellular …, 2019 - Wiley Online Library
Acute kidney injury (AKI) is a frequent and serious complication of sepsis; however, there
are currently no effective therapies. Inflammation and oxidative stress are the major …

[HTML][HTML] Dexmedetomidine alleviates hyperoxia-induced acute lung injury via inhibiting NLRP3 inflammasome activation

Q Zhang, D Wu, Y Yang, T Liu, H Liu - Cellular Physiology and …, 2017 - karger.com
Background/Aims: Dexmedetomidine (Dex), a specific agonist of α2-adrenoceptor, has been
reported to have extensive pharmacological effects. In this study, we focused on the …

Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial

ZX Wang, CY Huang, YP Hua… - British Journal of …, 2014 - academic.oup.com
Background We compared intestinal, hepatic, and other organ function after hepatic portal
occlusion with or without dexmedetomidine administration under general anaesthesia …

Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats

B Zheng, S Zhang, Y Ying, X Guo, H Li, L Xu… - Bioscience …, 2018 - portlandpress.com
The abnormally high nucleotide-binding oligomerization domain (NOD)-like receptor family
pyrin domain containing 3 (NLRP3) inflammasome activity is a typical characteristic of …

Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery

JP Cata, V Singh, BM Lee, J Villarreal… - Journal of …, 2017 - journals.lww.com
Results: After PSM and adjusting for significant covariates, the multivariate analysis
demonstrated no association between the use of dexmedetomidine and RFS (hazard ratio …

Dexmedetomidine exerts a protective effect on ischemia-reperfusion injury after hepatectomy: a prospective, randomized, controlled study

YU Zhang, M Liu, YU Yang, J Cao, W Mi - Journal of clinical anesthesia, 2020 - Elsevier
Study objective Dexmedetomidine, a highly selective α 2-receptor agonist, has been widely
used for protection against ischemia-reperfusion (IR) injury. We hypothesized that …

The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats

M Cakir, A Polat, S Tekin, N Vardi, E Taslidere… - Renal failure, 2015 - Taylor & Francis
Dexmedetomidine (dex) is a potent, highly selective and specific α2-adrenoreceptor agonist.
This experimental study was designed to investigate protective and therapeutic effect of two …